Concurrently, S&P revised its outlook on Bellin Health to negative from stable.
“The outlook revision reflects our view of Bellin’s proposed growth plans over the coming year, which, if they move forward as expected, could put pressure on the rating,” said S&P credit analyst Allison Bretz.
More articles on healthcare finance:
Highmark Health gifts Penn State Health $25M as part of $1B partnership
7 latest hospital credit downgrades
12 hospitals seeking RCM talent
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
